Price

rebased to 0%

ATYR, solidAMGN, dashed

ATYRaTYR PHARMA Inc

5.98−3.17%· post 5.74· delayed

Mkt cap$15.2MRevenue$235,000Q1 FY24Revenue—

AMGNAmgen Inc

461.49−3.55%· post 458.63· delayed

After hoursNov 5 '26delayed

Mkt cap$258.8BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

vs

Compare

After hoursNov 5 '26delayed

ATYRaTYR PHARMA Inc

vs

AMGNAmgen Inc

5.98−3.17%post 5.74delayed

Price

461.49−3.55%post 458.63delayed

$15.2M

Mkt cap

$258.8B

Q1 FY24$235,000

Revenue

$10.4BQ3 FY26

—

Revenue

$36.8BFY25

ATYR compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name